Sharon Grace
Vice President, Public Relations
703.838.0033 ext. 393

April 12, 2017

AMGA Foundation Presents Five Corporate Collaborator Awards
Foundation recognizes companies for outstanding support of national diabetes campaign

Alexandria, VA– AMGA Foundation recently presented five companies with Corporate Collaborator Awards for their outstanding support and involvement with the Foundation’s national campaign, Diabetes: Together 2 Goalâ. In just one year, Together 2 Goal®, in partnership with these Corporate Collaborators, has brought together over 150 member groups caring for more than 1 million patients with Type 2 diabetes.

The Foundation honored Novo Nordisk, Inc.; Janssen Pharmaceuticals; Optum, AMGA sustaining partner; Merck; and Sanofi for their commitment to tackling Type 2 diabetes with Together 2 Goal® on March 24 at AMGA’s Annual Conference in Grapevine, Texas.

“O“Our five Corporate Collaborators are indispensable partners to us,” said Jerry Penso, M.D. M.B.A., president of AMGA Foundation and chief medical and quality officer at AMGA. “Their support enables us to develop tools and resources, host events, and analyze data so that we can improve the lives of Americans living with Type 2 diabetes. We are grateful for their support.”

Presenting Corporate Collaborator
Novo Nordisk is Together 2 Goal®’s Presenting Corporate Collaborator, generously contributing $1.5 million to the campaign. They also support additional Foundation initiatives and serve on AMGA Foundation’s Chronic Care Roundtable, a forum for industry leaders, national clinical experts, and key stakeholders that shapes the Foundation’s national campaigns.

“We’re very pleased to receive this honor and to be involved with this campaign,” said Todd Hobbs, M.D., chief medical officer, Novo Nordisk US. “At Novo Nordisk, we believe in making an impact in diabetes and changing people’s lives, but we know that we can’t do it alone. It’s important for us to partner with likeminded organizations that have a similar passion, mission, and ability to really improve care for patients.”

Principal Corporate Collaborators
Janssen Pharmaceuticals Companies, of Johnson & Johnson, and Optum both were recognized for supporting the campaign at the $1 million level. Both organizations support additional Foundation activities and participate in the Chronic Care Roundtable.

“At J&J, our employees believe in a common mission to help people everywhere live longer, healthier, happier lives,” said Martine Thurin, J.D., M.S., group product director for metabolics at Janssen Pharmaceuticals Companies of Johnson & Johnson. “So, we are proud to be a part of this collaboration, as it represents a great opportunity for healthcare stakeholders to collectively advance the management of patients living with Type 2 Diabetes, and an exciting opportunity to WIN for patients”

“We are honored to be recognized by AMGA Foundation,” said Lisa Tseng, M.D., executive vice president at Optum. “Population health analytics are critical to achieving insights that pave the way to positive health outcomes. We value the opportunity to work with the country’s leading medical groups to identify evidence-based best practices for treating patients with diabetes and other chronic conditions.”

Contributing Corporate Collaborators
Merck and Sanofi also were honored for their support of the campaign. Both organizations are longtime supporters of both AMGA and AMGA Foundation initiatives such as the Best Practices Learning Collaboratives. In addition to Together 2 Goalâ, both also participate in the Chronic Care Roundtable.

About the Together 2 Goal® Campaign
AMGA Foundation, the nonprofit arm of AMGA, launched Together 2 Goal®, a three-year national campaign to fight the challenge of type 2 diabetes on March 12, 2016. Together 2 Goal® includes over 150 medical groups, health systems, non-profit partners, and corporate collaborators such as the American Diabetes Association, American Association of Diabetes Educators, Novo Nordisk, Inc., Geisinger Health System, Henry Ford Health System, Intermountain Healthcare, and Ochsner Health System. The goal of the three-year campaign is to improve care for 1 million people with type 2 diabetes by 2019. 

About AMGA Foundation
AMGA Foundation is AMGA’s philanthropic arm that enables medical groups and other organized systems of care to consistently improve health and health care. AMGA Foundation serves as a catalyst, connector and collaborator for translating the evidence of what works best in improving health and health care in everyday practice. Learn more at

About AMGA
AMGA is a trade association leading the transformation of health care in America. Representing multispecialty medical groups and integrated systems of care, we advocate, educate, innovate and empower our members to deliver the next level of high performance health. AMGA is the national voice promoting awareness of medical groups’ recognized excellence in the delivery of coordinated, high-quality, cost-effective care. More than 175,000 physicians practice in our member organizations, delivering care to one in three Americans. Learn more at